The molecular scaffold Gab2 is a crucial component of RANK signaling and osteoclastogenesis
- 6 March 2005
- journal article
- research article
- Published by Springer Nature in Nature Medicine
- Vol. 11 (4) , 394-399
- https://doi.org/10.1038/nm1203
Abstract
Morphogenesis and remodeling of bone involve synthesis of bone matrix by osteoblasts and coordinate resorption of bone by osteoclasts. Defective bone remodeling caused by altered osteoclast activity underlies a multitude of osteopenic disorders. Receptor activator of NF-κB (RANK) and its ligand RANKL have been identified as essential factors involved in osteoclast development and bone remodeling, but their mechanism and interacting factors have not been fully characterized. Here we report that the molecular adapter Grb-2-associated binder-2 (Gab2) associates with RANK and mediates RANK-induced activation of NF-κB, Akt and Jnk. Inactivation of the gene encoding Gab2 in mice results in osteopetrosis and decreased bone resorption as a result of defective osteoclast differentiation. We also show that Gab2 has a crucial role in the differentiation of human progenitor cells into osteoclasts. We have thus identified a new, key regulatory scaffold molecule, Gab2, that controls select RANK signaling pathways and is essential for osteoclastogenesis and bone homeostasis.Keywords
This publication has 27 references indexed in Scilit:
- Genetic regulation of osteoclast development and functionNature Reviews Genetics, 2003
- Critical role for scaffolding adapter Gab2 in FcγR-mediated phagocytosisThe Journal of cell biology, 2003
- Osteoclast differentiation and activationNature, 2003
- Gab3-Deficient Mice Exhibit Normal Development and Hematopoiesis and Are ImmunocompetentMolecular and Cellular Biology, 2003
- RANK-L and RANK: T Cells, Bone Loss, and Mammalian EvolutionAnnual Review of Immunology, 2002
- The gift of GabFEBS Letters, 2002
- Docking Protein Gab2 Is Phosphorylated by ZAP-70 and Negatively Regulates T Cell Receptor Signaling by Recruitment of Inhibitory MoleculesJournal of Biological Chemistry, 2001
- Osteoclast Differentiation Factor (ODF) Induces Osteoclast-like Cell Formation in Human Peripheral Blood Mononuclear Cell CulturesBiochemical and Biophysical Research Communications, 1998
- A Grb2-associated docking protein in EGF- and insulin-receptor signallingNature, 1996
- Wortmannin, a specific inhibitor of phosphatidylinositol‐3 kinase, blocks osteoclastic bone resorptionFEBS Letters, 1995